Flexible, Patient Capital
K2HV looks to partner with and provide capital to innovative life sciences and healthcare companies that intend to pursue aggressive development or growth plans, but also want to minimize equity dilution as they build enterprise value over the long-term. We invest in both private and public companies.
Experience to understand the unique needs of venture and growth stage healthcare and life sciences companies
Deep domain knowledge to understand your products, your business and value proposition, as well as your challenges
UNIQUE SCALE AND FLEXIBILITY
Substantial capital resources and strong financial backing; initial capital commitment of $400 million creates capacity for immediate, impactful investments
Target investments of between $10 million and $50 million per company
Flexible capital structure enables creative, adaptive financing solutions tailored to company needs
Primary focus on customized debt financings, but with ability to invest in equity as well
PERMANENT FUND STRUCTURE
Permanent capital supports a patient, long-term investment view – not tied to fixed investment time horizons or fund cycles
Fund structure enables us to meet the increasing and evolving capital needs of our portfolio companies as they grow
Asset base expected to grow substantially beyond the initial capital commitment over time
WHAT DRIVES US: PROFIT WITH PURPOSE
At K2HV we are driven by dual goals of Profit and Purpose, and by our fundamental desire and passion to improve outcomes for patients. We aim to enable the next generation of innovations by life sciences and healthcare companies whose success will help to further that objective.
In keeping with this mission, we have also committed to giving a percentage of our own profits back to underserved areas in healthcare.